The draft guidance addresses criticisms that pulse oximeters are less accurate for people with dark skin tones. Experts ...

Masimo impressed with a robust earnings report driven by its healthcare segment, despite challenges from non-healthcare operations.

M&T Bank Corp grew its position in shares of Masimo Co. (NASDAQ:MASI – Free Report) by 4.9% in the 4th quarter, ...

Masimo is a leading medical technology company that specializes in noninvasive monitoring devices. It develops innovative technologies used in pulse oximetry, providing critical health metrics ...

Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry ...

Masimo is positioned at the forefront of noninvasive monitoring technologies, notably with its SET and rainbow SET Pulse CO-Oximetry systems. These innovations enhance patient care by providing ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...